Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Saturday, September 30, 2023.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2023 (2023-09-30): -858.49%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-448.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-413.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-166.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NRx Pharmaceuticals, Inc.
Market Cap
$124.91M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-448.43%
3Y Avg
-413.61%
5Y Avg
-166.56%
Market Cap
$122.93M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
Market Cap
$122.89M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-23.22%
3Y Avg
-53.77%
5Y Avg
-63.92%
Market Cap
$121.90M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
Market Cap
$128.40M
Return on Invested Capital (ROIC)
-82.87%
TTM Avg
-100.14%
3Y Avg
-98.73%
5Y Avg
-97.80%
Market Cap
$118.68M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
Market Cap
$131.43M
Return on Invested Capital (ROIC)
-21.42%
TTM Avg
-8.92%
3Y Avg
-14.86%
5Y Avg
-16.42%
Market Cap
$118.02M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$117.29M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $124.91M | N/A | -448.43% | -413.61% | -166.56% |
| enGene Holdings Inc. (ENGN)vs › | $122.93M | -1.78% | -41.34% | -32.26% | -28.21% |
| Cibus, Inc. (CBUS)vs › | $122.89M | -17.99% | -23.22% | -53.77% | -63.92% |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.90M | -137.40% | -133.78% | -372.93% | -315.43% |
| Entera Bio Ltd. (ENTX)vs › | $128.40M | -82.87% | -100.14% | -98.73% | -97.80% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.68M | -61.84% | -30.30% | -57.06% | -116.42% |
| Health Catalyst, Inc. (HCAT)vs › | $131.43M | -21.42% | -8.92% | -14.86% | -16.42% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -87.72% | -74.88% | -52.32% | -62.32% |
| Coya Therapeutics, Inc. (COYA)vs › | $117.29M | -0.05% | -44.27% | -81.25% | -78.53% |
| Genelux Corporation (GNLX)vs › | $116.59M | -192.18% | -186.03% | -161.77% | -220.86% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2023-09-30 | -858.49% |
| 2023-06-30 | -368.29% |
| 2023-03-31 | -319.73% |
| 2022-12-31 | -247.21% |
| 2022-03-31 | -328.78% |
| 2021-12-31 | -446.45% |
| 2021-09-30 | -559.62% |
| 2020-09-30 | -180.32% |
| 2020-06-30 | -31.89% |
| 2020-03-31 | -7.37% |
| 2019-12-31 | -1.88% |
| 2019-09-30 | -1.83% |
| 2019-06-30 | -1.51% |
| 2019-03-31 | -1.16% |
| 2018-12-31 | -1.15% |
| 2018-09-30 | -1.18% |
